Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Haggitt

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Cancer Research|October 15, 1991
Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancersR F Boynton, Y Huang, P L Blount, et al.
Gastroenterology|November 1, 1992
DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitisC E Rubin, R C Haggitt, G C Burmer, et al.
Sexually Transmitted Diseases|November 24, 1999
Safety and toxicity of nonoxynol-9 gel as a rectal microbicideS R Tabet, C Surawicz, S Horton, et al.
Archives of Pathology & Laboratory Medicine|June 1, 1982
Carcinoma or dysplasia in Crohn's diseaseR C Haggitt, H D Appelman, P Correa, et al.
Gastroenterology|February 1, 1996
Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitisT A Brentnall, R C Haggitt, P S Rabinovitch, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1992
Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancersR F Boynton, P L Blount, J Yin, et al.
Gastroenterology|March 1, 1997
Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591W G Roberts, T J Simon, R G Berlin, et al.
The American Journal of Pathology|September 12, 2000
The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasiaS N Agoff, T A Brentnall, D A Crispin, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Cancer Research|October 15, 1991
Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancersR F Boynton, Y Huang, P L Blount, et al.
Gastroenterology|November 1, 1992
DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitisC E Rubin, R C Haggitt, G C Burmer, et al.
Sexually Transmitted Diseases|November 24, 1999
Safety and toxicity of nonoxynol-9 gel as a rectal microbicideS R Tabet, C Surawicz, S Horton, et al.
Archives of Pathology & Laboratory Medicine|June 1, 1982
Carcinoma or dysplasia in Crohn's diseaseR C Haggitt, H D Appelman, P Correa, et al.
Gastroenterology|February 1, 1996
Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitisT A Brentnall, R C Haggitt, P S Rabinovitch, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1992
Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancersR F Boynton, P L Blount, J Yin, et al.
Gastroenterology|March 1, 1997
Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591W G Roberts, T J Simon, R G Berlin, et al.
The American Journal of Pathology|September 12, 2000
The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasiaS N Agoff, T A Brentnall, D A Crispin, et al.
Pageof 11